作者: Elizabeth Catherine Smyth , Sanna Hulkki Wilson , Matthew Guy Nankivell , David Gonzalez de Castro , Andrew Wotherspoon
DOI: 10.1200/JCO.2015.33.3_SUPPL.62
关键词: Resection 、 Perioperative 、 Microsatellite instability 、 Colorectal cancer 、 Oncology 、 Tp53 mutation 、 Pathology 、 Medicine 、 Esophagus 、 Chemotherapy 、 Internal medicine 、 Kras mutation
摘要: 62 Background: MSI is prognostic for survival in diverse cancers and predicts resistance to fluoropyrimidine chemotherapy colon cancer. We examined the interaction between patient (pt) characteristics pts randomised surgery alone or perioperative ECF MRC MAGIC trial. Methods: Tumor normal control DNA was extracted from resection FFPE. status determined using Promega Analysis System (NR-21, BAT-26, BAT-25, NR-24, MONO-27). Tumors were classified as MSS when all markers stable, MSI-L only one marker unstable MSI-H with minimum of instability two markers. correlated pt survival. Results: results available 303 (66% resected pts). Twenty (6.6%) 2 (0.6%) MSI-L. All had stomach tumors (vs.GEJ/esophagus). KRAS mutation more common tumours (30% vs. 4%, p-value <0.001); rates BRAF, PIK3CA TP53 mutations com...